NEXGEL, INC. Logo

NEXGEL, INC.

Develops and manufactures advanced hydrogels for healthcare, OTC, and consumer applications.

NXGL | US

Overview

Corporate Details

ISIN(s):
US65344E1073
LEI:
Country:
United States of America
Address:
2150 CABOT BLVD WEST,, 19047 LANGHORNE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

NEXGEL, Inc. is a technology company that develops and manufactures advanced, high-water-content hydrogels. Utilizing an electron-beam cross-linking process, the company produces ultra-gentle hydrogel products for healthcare, over-the-counter (OTC), and consumer applications. Its versatile platform is used for wound care, transdermal delivery of active ingredients, beauty and cosmetic treatments, and foot care. Operating from an FDA-registered and ISO-certified cGMP manufacturing facility, NEXGEL offers a range of proprietary formulations, including biodegradable options, and provides custom development services for business partners to deliver their unique ingredients via a hydrogel system.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NEXGEL, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NEXGEL, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NEXGEL, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Denali Therapeutics Inc. Logo
Developing therapies for neurodegenerative diseases that cross the blood-brain barrier.
United States of America DNLI
Dermapharm Holding SE Logo
Manufactures patent-free branded pharmaceuticals & healthcare products for niche markets.
Germany DMP
Dermata Therapeutics, Inc. Logo
Develops OTC skin treatments using a unique delivery technology from freshwater sponges.
United States of America DRMA
Design Therapeutics, Inc. Logo
Develops small molecule genomic medicines to treat serious genetic diseases by modulating genes.
United States of America DSGN
Deutsche Biotech Innovativ AG Logo
Develops biomarker-driven therapeutics and diagnostics for serious diseases with unmet needs.
Germany DBI
DEVA HOLDİNG A.Ş. Logo
Global manufacturer of human/veterinary pharmaceuticals, APIs, and medical ampoules.
Spain DEVA
Devyser Diagnostics Logo
Develops & sells genetic DNA test kits for labs in oncology, transplant & reproductive health.
Sweden DVYSR
DiaMedica Therapeutics Inc. Logo
Developing a novel protein therapy for acute ischemic stroke and preeclampsia.
United States of America DMAC
Diamyd Medical AB (publ) Logo
Developing precision immunotherapies to preserve insulin in autoimmune diabetes.
Sweden DMYD
Dianthus Therapeutics, Inc. /DE/ Logo
Developing selective antibody therapies for severe autoimmune diseases.
United States of America DNTH

Talk to a Data Expert

Have a question? We'll get back to you promptly.